Amsterdam-based Tebi Announces €30 Million Investment Led by Alphabet growth fund CapitalG to transform hospitality operations
Investment to accelerate product development, hiring, and global expansion
Tebi, the Amsterdam-based startup developing an all-in-one financial operating system for hospitality, today announced a €30 million investment led by Alphabet independent growth fund CapitalG, with participation from existing investor Index Ventures. This follows Tebi’s €20 million Series A announced just six months ago and brings the company’s total funding to €56 million.
The financing reflects the company’s momentum across product innovation, hiring and expansion into new markets. The investment will support Tebi’s continued growth in these key areas of focus.
The company was founded in 2021 by technical alumni from Adyen, a €45B Dutch company, including serial entrepreneur Arnout Schuijff as CEO and Rob Vonk as CTO. Tebi is the third company co-founded by Schuijff, who previously served as Adyen’s longtime CTO and co-founder.
Aki Tas, former head of business strategy and operations at Notion, joined last fall as COO to lead the product, marketing, and foundation teams, and Patrick Studener, former COO at Wolt (now part of Doordash) and previous head of European expansion at Uber, joined at the beginning of the year as CCO to lead operational teams.
The investment will fuel Tebi's mission to transform operations for hospitality businesses worldwide. Until now, businesses have had to cobble together difficult-to-use solutions that lack key features, handle back-office tasks slowly and manually, and make it difficult to assess business performance. Tebi is rethinking hospitality technology from the ground-up, unifying the point of sale, payments, inventory management, a kitchen display system, reservations, and QR ordering functionality through an intuitive, mobile-first platform built on an accounting backbone. By being built around the point of sale, Tebi can coordinate both operations and finances for complex hospitality businesses. AI-enabled onboarding enables businesses to get started quickly, while the comprehensive platform simplifies and unifies workflows and makes key business metrics easily viewable.
Merchants across the Netherlands are already processing nine figures of payments annually on the platform. With this new investment, Tebi plans to accelerate product development, expand its reach globally, and grow its team. Beginning today, Tebi will also begin serving the UK market, marking the beginning of a broader global expansion strategy (UK customers can find Tebi at tebi.com/gb/).
"Hospitality businesses are the lifeblood of our communities, yet they've been underserved by technology, especially here in Europe," said Arnout Schuijff, co-founder and CEO of Tebi. "No one opens a restaurant or store because they love paperwork and integrating tools; they do it for the passion of serving people. It’s a privilege to build a world-class team devoted to empowering European business owners to free up time to focus on the craft and customers they cherish.”
“We are thrilled to partner with Tebi as they build the operating system for hospitality businesses,” said Alex Nichols, Partner at CapitalG. “Even though most small business front and back office workflows revolve around payments, three-quarters of Europe’s SMB payments are disconnected from software. By unifying these disjointed systems, Tebi is bringing greater efficiency and visibility to small business owners’ daily work. Arnout and his team combine focused customer centricity, speed, and unique founder-market fit. We couldn’t imagine a better team to pursue this massive opportunity.”
"Moving from disconnected systems – our previous POS software, a separate reservations platform, paper kitchen tickets, and a standalone payments provider – to Tebi's single integrated platform led us to embrace a new mindset at Zoldering. We approached it as if we were starting fresh, letting go of old habits to realize a seamless workflow from reservation to service to kitchen. Tebi has not just replaced our old systems; it has enabled a new way of working by unifying our data, streamlining communication between front and back of house, and offering the flexibility to adapt workflows to our specific needs – exactly what's required to maintain the standards expected of a Michelin-starred restaurant,” said Tomas and Job from Zoldering.
Tebi currently employs 35 people and is planning to double its headcount by the end of the year with roles open in Amsterdam and London.
About Tebi
Tebi is an all-in-one financial operating system for independent hospitality businesses. Founded in 2021, Tebi provides a comprehensive, mobile-first solution that includes point of sale, integrated payments, a kitchen display system, reservations, inventory management, QR ordering, and bookkeeping. With its unique pricing model and commitment to merchant success, Tebi is dedicated to empowering hospitality businesses everywhere. To learn more about adopting Tebi for your business, visit www.tebi.com.
Tebi is currently hiring across all functions, including engineering, product management and operations in both Amsterdam and London. Visit Tebi’s careers page to see all open positions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610225196/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 00:45:00 CEST | Press release
POD1UM-303/InterAACT 2 is the first and largest global Phase 3 trial evaluating a PD-1 inhibitor in combination with chemotherapy for the treatment of patients with advanced SCAC not previously treated with systemic chemotherapy The trial met its primary endpoint; treatment with retifanlimab in combination with platinum-based chemotherapy (carboplatin-paclitaxel) resulted in clinically meaningful improvements in progression-free survival and overall survival In May 2025, the U.S. Food and Drug Administration (FDA) approved Zynyz® (retifanlimab-dlwr) in combination with carboplatin and paclitaxel and as a single agent for the treatment of advanced SCAC; submissions to other global regulatory agencies are also under review Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-base
Güntner Drives Group-Wide Innovation in 2024 Sustainability Report12.6.2025 21:30:00 CEST | Press release
Progress in natural refrigerants, water efficiency and circular economy underscores Güntner’s global impact Güntner, a global leader in refrigeration and heat exchange technology, today announced its featured role in the newly released 2024 A-HEAT Sustainability Report. The report outlines significant progress toward ambitious environmental goals—fueled by Güntner’s commitment to measurable, innovation-led sustainability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612897493/en/ Güntner advances global sustainability goals with progress in natural refrigerants, water savings, and circular economy efforts. Working toward its 2030 sustainability targets, Güntner delivered significant achievements across key areas including natural refrigeration integration, water and energy efficiency and the development of circular economy solutions. These efforts reflect Güntner’s ongoing mission to make sustainability not just a goal,
Windsurf Launches First GPU Cluster in Germany, Expanding Secure Enterprise AI in Europe12.6.2025 20:45:00 CEST | Press release
Windsurf launches a GPU cluster in Germany, delivering 50% faster performance and secure access to European enterprises. Data residency ensures enterprise repositories stay within the EU, meeting stringent security requirements. Windsurf already supports 100+ European enterprise customers, highlighting strong demand for AI-powered development tools across EMEA. Windsurf, a leader in AI-powered software development, today announced its first GPU cluster in Germany, as product demand surges and the company expands performance capacity across the EU. With over 100 local enterprise customers already using Windsurf products, the new cluster marks the company’s first major international step in building scalable infrastructure for the European market. Located in Frankfurt, home to some of the world’s strictest data security laws, the cluster was a natural choice for Windsurf’s first deployment. This cluster was specifically designed to meet the unique security and performance requirements of
Xsolla Partners With Defold to Enable Seamless In-game Purchases for Web Developers12.6.2025 19:00:00 CEST | Press release
New SDK Integration Simplifies Monetization for Defold Developers Publishing on CrazyGames Ahead of Global Game Jam Xsolla, a leading global video game commerce company, announces a new strategic partnership with Defold, the cross-platform game engine trusted by professionals and indie developers worldwide. This collaboration introduces a seamless integration between Xsolla and Defold-built web games on CrazyGames, enabling developers to easily monetize their titles just in time for the CrazyGames x Defold Game Jam running June 13–15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612569206/en/ (Graphic: Xsolla) To address the complexity of in-game monetization, Xsolla and Defold have developed a new SDK that allows Defold developers to implement in-game purchasing functionality without the complex manual API setup required. With Xsolla’s sponsorship and support, this integration removes friction from the monetization jou
Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 17:00:00 CEST | Press release
The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom